Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Transplantation ; 108(9): e254-e263, 2024 Sep 01.
Artigo em Inglês | MEDLINE | ID: mdl-38499511

RESUMO

BACKGROUND: The outcomes after kidney transplantation (KT), including access, wait time, and other issues around the globe, have been studied. However, issues do vary from one country to another. METHODS: We obtained data from several countries from North America, South America, Europe, Asia, and Australia, including the number of patients awaiting KT from 2015, transplant rate per million population (pmp), proportion of living donor and deceased donor (LD/DD) KT, and posttransplant survival. We also sought opinions on key difficulties faced by each of these countries with respect to KT and long-term survival. RESULTS: Variation in access to KT across the globe was noted. Countries with the highest rates of KT pmp included the United States (79%) and Spain (71%). A higher proportion of LD transplants was noted in Japan (93%), India (85%), Singapore (63%), and South Korea (63%). A higher proportion of DD KTs was noted in Spain (90%), Brazil (90%), France (85%), Italy (85%), Finland (85%), Australia-New Zealand (80%), and the United States (77%). The 5-y graft survival for LD was highest in South Korea (95%), Singapore (94%), Italy (93%), Finland (93%), and Japan (93%), whereas for DD, it was South Korea (93%), Italy (88%), Japan (86%), and Singapore (86%). The common issues surrounding KTs are access and a limited number of LDs and DDs. Key issues identified for long-term survival were increasing age of donors and recipients, higher recipient comorbidity, and posttransplant events, such as alloimmune injury to the kidney, infection, cancer, and suboptimal adherence to therapy. CONCLUSIONS: A unified approach is necessary to improve issues surrounding KT as the demand continues to increase.


Assuntos
Sobrevivência de Enxerto , Transplante de Rim , Humanos , Transplante de Rim/mortalidade , Transplante de Rim/efeitos adversos , Transplante de Rim/estatística & dados numéricos , Fatores de Tempo , Resultado do Tratamento , Listas de Espera/mortalidade , Doadores Vivos , Fatores de Risco , Acessibilidade aos Serviços de Saúde/estatística & dados numéricos , Saúde Global , Doadores de Tecidos/provisão & distribuição , Doadores de Tecidos/estatística & dados numéricos
2.
Transplantation ; 95(11): 1306-12, 2013 Jun 15.
Artigo em Inglês | MEDLINE | ID: mdl-23644753

RESUMO

By 2005, human organ trafficking, commercialization, and transplant tourism had become a prominent and pervasive influence on transplantation therapy. The most common source of organs was impoverished people in India, Pakistan, Egypt, and the Philippines, deceased organ donors in Colombia, and executed prisoners in China. In response, in May 2008, The Transplantation Society and the International Society of Nephrology developed the Declaration of Istanbul on Organ Trafficking and Transplant Tourism consisting of a preamble, a set of principles, and a series of proposals. Promulgation of the Declaration of Istanbul and the formation of the Declaration of Istanbul Custodian Group to promote and uphold its principles have demonstrated that concerted, strategic, collaborative, and persistent actions by professionals can deliver tangible changes. Over the past 5 years, the Declaration of Istanbul Custodian Group organized and encouraged cooperation among professional bodies and relevant international, regional, and national governmental organizations, which has produced significant progress in combating organ trafficking and transplant tourism around the world. At a fifth anniversary meeting in Qatar in April 2013, the DICG took note of this progress and set forth in a Communiqué a number of specific activities and resolved to further engage groups from many sectors in working toward the Declaration's objectives.


Assuntos
Ética Profissional , Cooperação Internacional , Turismo Médico/ética , Transplante de Órgãos/ética , Obtenção de Tecidos e Órgãos/ética , China , Colômbia , Egito , Humanos , Índia , Turismo Médico/legislação & jurisprudência , Transplante de Órgãos/legislação & jurisprudência , Paquistão , Filipinas , Catar , Sociedades Médicas , Obtenção de Tecidos e Órgãos/legislação & jurisprudência , Turquia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA